Other OTC - Delayed Quote • USD Mauna Kea Technologies SA (MKEAF) Follow 0.3700 0.0000 (0.00%) At close: March 21 at 2:46 PM EDT Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for MKEAF 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: MKEAF View More All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Mauna Kea Technologies Reports Full Year 2023 Results and Q1 2024 Sales Mauna Kea Technologies Executes Agreement to Restructure its Existing Loan Agreement with the European Investment Bank Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital Mauna Kea Technologies Announces the Opening of the First Italian Center of Excellence for the Use of Cellvizio® to Identify and Treat Food Intolerance in Adults Mauna Kea Technologies Partners with V7 to Develop Innovative AI Applications with Cellvizio Mauna Kea Technologies Partners with Metrodora to Create First U.S. Center of Excellence for the Use of Cellvizio® to Identify and Treat Food Intolerance in Adults Mauna Kea Technologies Welcomes Benoit Chardon as Senior Advisor to Scale its Irritable Bowel Syndrome and Food Intolerance Business Mauna Kea Technologies Announces Initiation of Coverage by EuroLand Corporate MAUNA KEA TECHNOLOGIES: Half-Year Liquidity Contract Statement for H2 2023 with the Brokerage Firm Gilbert Dupont Mauna Kea Technologies Reports Full Year 2023 Sales of €10.5m, Up +42%1 vs 2022 Mauna Kea Technologies and Telix Pharmaceuticals to Expand Partnership in Uro-oncologic Surgery Mauna Kea Technologies Announces First Patient Enrolled in the Pivotal CLEVER Clinical Trial in Peripheral Lung Cancer Related Tickers OFIX Orthofix Medical Inc. 12.99 -0.84% RBOT Vicarious Surgical Inc. 0.2700 +2.66% ZBH Zimmer Biomet Holdings, Inc. 119.35 -0.33% SYK Stryker Corporation 335.61 -0.46% ASXC Asensus Surgical, Inc. 0.2490 +3.32% DXCM DexCom, Inc. 124.34 -9.91%
